The cyclin D1-CDK4 oncogenic interactome enables identification of potential novel oncogenes and clinical prognosis
2014 · Cell Cycle · 28 citations
https://doi.org/10.4161/15384101.2014.946850
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
12
Papers
664
Citations
8
h-index
7
i10-index
Samanta Sharma is an academic researcher from AstraZeneca (United States). The author has contributed to research in topics: Cancer-related Molecular Pathways & Ubiquitin and proteasome pathways & Protein Degradation and Inhibitors. The author has an h-index of 8, co-authored 11 publications.
ORCID: 0000-0001-9988-8684https://doi.org/10.4161/15384101.2014.946850
https://doi.org/10.6084/m9.figshare.1571356
https://doi.org/10.6084/m9.figshare.13007873
Click to start Chat